Cargando…
Palliative low dose fortnightly methotrexate in oral cancers: Experience at a rural cancer centre from India
CONTEXT: Palliative fortnightly chemotherapy in oral cancers. AIMS: We present our experience with a regimen employing fortnightly (once in 2 weeks) injectable methotrexate (MTX) (40 mg/m(2) ) in a predominantly elderly cohort of patients with carcinoma of oral cavity and oropharynx. SETTINGS AND DE...
Autores principales: | Chakraborty, Santam, Geetha, M., Sujith, K. M., Biji, M. S., Sateeshan, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134608/ https://www.ncbi.nlm.nih.gov/pubmed/25136524 http://dx.doi.org/10.4103/2278-330X.136798 |
Ejemplares similares
-
Palliative low dose fortnightly methotrexate in oral cancer
por: Tin, Sim Sai, et al.
Publicado: (2015) -
A Nordic survey of the management of palliative care in patients with head and neck cancer
por: Boëthius, Helena, et al.
Publicado: (2020) -
Imaging in laryngeal cancers
por: Joshi, Varsha M, et al.
Publicado: (2012) -
An audit of the results of a triplet metronomic chemotherapy regimen incorporating a tyrosine kinase inhibitor in recurrent/metastatic head and neck cancers patients
por: Patil, Vijay M., et al.
Publicado: (2016) -
Imaging in oral cancers
por: Arya, Supreeta, et al.
Publicado: (2012)